Outcome of tailored antiplatelet therapy in carotid stenting: a retrospective comparative study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tailoring antiplatelet therapy using platelet function testing for carotid stenting significantly reduced procedure-related stroke and death. This personalized approach appears safer than standard dual antiplatelet therapy, warranting further investigation.
Area Of Science
- Cardiovascular Medicine
- Interventional Neurology
- Pharmacology
Background
- Carotid stenting necessitates dual antiplatelet therapy to prevent thromboembolic events.
- Clopidogrel resistance poses a persistent risk for these complications.
- Routine platelet function testing (PFT) was investigated to optimize antiplatelet therapy.
Purpose Of The Study
- To determine if routine PFT and adjusted antiplatelet therapy reduce thromboembolic complications and death after carotid stenting.
- To compare outcomes with established clinical trial data.
Main Methods
- Retrospective analysis of 241 patients undergoing carotid artery stenting over 8 years.
- Platelet function testing performed pre-procedure to guide antiplatelet therapy.
- Procedure-related stroke or death incidence (0-30 days) assessed and compared to CREST and ICSS trials.
Main Results
- Five thromboembolic complications (2.01%) occurred; 4 (1.61%) were procedure-related.
- Two deaths (0.82%) resulted from procedure-related stroke.
- Lower incidence of procedure-related stroke/death compared to CREST (2.01% vs. 4.81%) and ICSS (2.86% vs. 7.37%) in relevant cohorts.
Conclusions
- Tailored antiplatelet therapy guided by PFT is safe in carotid stenting.
- This approach appears associated with a reduced rate of procedure-related death or stroke.
- Larger prospective studies are needed to confirm superiority over standard dual antiplatelet therapy.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...